Company expects preliminary unaudited AUCATZYL® net product revenue of approximately $24 million for the fourth quarter of 2025 and approximately $75 million for the full year of 2025Autolus anticipat ...

People with hepatitis C virus who inject drugs could be evaluated for cure approximately 2 months earlier than current ...

Atea Pharmaceuticals, Inc. Phase 3 Topline Results for Potential Best-in-Class Regimen for Treatment of HCV on Track for 2026 ...

MyBioSource, a trusted global supplier of premium research reagents, offers five types of PCR kits, tailored to different experimental requirements. These ready-to-use kits include high-quality ...

The CDC has this week recommended a new vaccine schedule with several vaccines removed from the recommended schedule. The CDC recommends continuing the current schedule for the following vaccines: ...

The American Association for the Study of Liver Diseases and Infectious Diseases Society of America have updated guidance on ...

A new rapid test for hepatitis C could help identify many more patients who could be cured of the deadly disease, but its use may be limited unless insurers' reimbursement rises to cover its high cost ...

Next-day HIV viral load testing results do not significantly improve linkage to treatment or prevention care for adults at risk for acquisition or people with HIV not receiving daily antiretroviral ...

TUESDAY, Dec. 23, 2025 (HealthDay News) -- For adults at risk for HIV acquisition or people with HIV (PWH) not taking daily antiretroviral therapy (ART), an HIV viral load (VL) test with next-day ...

Millions of people in the U.S. and around the world are living with hepatitis C virus (HCV). But over the past decade, direct-acting antivirals (DAA) have proven effective against HCV, curing more ...

Northwestern scientists have created the fastest-ever hepatitis C diagnostic, delivering accurate results in only 15 minutes. The test uses the DASH rapid PCR system, originally developed for COVID, ...